Earning (Loss) Per Share (Tables)

6 Months Ended

Jun. 30, 2023

Earnings Per Share [Abstract]

Schedule of Earnings Per Share

The earnings (loss) per share accounting guidance is discussed in Note 1. The following table sets forth the computation of the Company’s basic and diluted net earnings (loss) per share available to common stockholders (unaudited) for the three and six months ended June 30, 2023 and 2022:

	Three Months Ended June 30,						Six Months Ended June 30,
	2023			2022			2023			2022
Numerator
Net income (loss) from continuing operations	$	1,285,930		$	(499,841	)	$	2,091,490		$	(2,765,973	)
Deemed dividends		-			(194,951,624	)		-			(330,876,369	)
Net income (loss) available to common stockholders, continuing operations		1,285,930			(195,451,465	)		2,091,490			(333,642,342	)
Net loss from discontinued operations		(8,097	)		(3,945	)		(8,097	)		(5,379	)
Net income (loss) available to common stockholders	$	1,277,833		$	(195,455,410	)	$	2,083,393		$	(333,647,721	)
Denominator
Weighted average number of shares of common stock outstanding during the period - basic		29,934,322,257			1,702,149,425			29,845,095,738			858,169,865
Warrants		-			-			6,335,103,465			-
Preferred stock		452,145,411,111			-			452,234,637,630			-
Weighted average number of shares of common stock outstanding during the period - diluted		482,079,733,368			1,702,149,425			488,414,836,833			858,169,865
Net earnings (loss) available to common stockholders per share - basic:
Continuing operations	$	0.00		$	(0.11	)	$	0.00		$	(0.39	)
Discontinued operations		(0.00	)		(0.00	)		(0.00	)		(0.00	)
Total basic	$	0.00		$	(0.11	)	$	0.00		$	(0.39	)
Net earnings (loss) available to common stockholders per share - diluted:
Continuing operations	$	0.00		$	(0.11	)	$	0.00		$	(0.39	)
Discontinued operations		(0.00	)		(0.00	)		(0.00	)		(0.00	)
Total diluted	$	0.00		$	(0.11	)	$	0.00		$	(0.39	)

Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share

Diluted earnings (loss) per share excludes all dilutive potential shares if their effect is anti-dilutive.

For the three months ended June 30, 2023 and 2022, the following potential common stock equivalents were excluded from the calculation of diluted earnings (loss) per share as their effect was anti-dilutive:

	Three Months Ended June 30,
	2023		2022
Common stock warrants		511,333,351,089		511,333,351,097
Convertible preferred stock		-		477,576,633,334
Convertible debentures		28,777,833,333		28,777,833,333
Stock options		26		26
		540,111,184,448		1,017,687,817,790

For the six months ended June 30, 2023 and 2022, the following potential common stock equivalents were excluded from the calculation of diluted earnings (loss) per share as their effect was anti-dilutive:

	Six Months Ended June 30,
	2023		2022
Common stock warrants		504,998,247,624		511,333,351,097
Convertible preferred stock		-		477,576,633,334
Convertible debentures		28,777,833,333		28,777,833,333
Stock options		26		26
		533,776,080,983		1,017,687,817,790